News by Subject Social & Behavior

People with gambling problems are less likely to consider important information that could prevent them from losing, according to new research published today from the UBC's Centre for Gambling Research.

In a new study that could turn what we know about birth order upside down, a University of Houston researcher has found that the role of birth order on career types, occupational creativity and status attainment might have been overestimated in previous research.

Nature Human Behavior published the research by scientists at Emory University. It gives the first detailed view of ventral striatum activity during three phases of effort-based decision-making -- the anticipation of initiating an effort, the actual execution of the effort and the reward, or outcome, of the effort.

Many patients start hemodialysis with temporary vascular access despite regular kidney care and pre-dialysis education. Delay is often related to patient choice but research on patients' perspectives is limited. In this study, researchers surveyed pre-dialysis patients and their family members about their perceptions of chronic kidney disease (CKD) and their intentions to undergo access creation. They also report on a new survey instrument to measure attitudes towards hemodialysis preparation.

A new study by a University of Houston psychologist may hold the key to job success. It finds young people who develop higher levels of conscientiousness and emotional stability during the transition to employment tend to be more successful in some aspects of their early careers.

With a large percentage of women in the workplace aged between 40 and 59 years, the challenge of women managing menopause symptoms while at work is commonplace. A new study examined the relationship between the number of menopause symptoms and the job performance of working women. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS).

Just a few doses of an experimental drug can reverse age-related declines in memory and mental flexibility in mice, according to a new study by UC San Francisco scientists. The drug, called ISRIB, has already been shown in laboratory studies to restore memory function months after traumatic brain injury (TBI), reverse cognitive impairments in Down Syndrome, prevent noise-related hearing loss, fight certain types of prostate cancer, and even enhance cognition in healthy animals.